Earnings Feed
Start Free
Home/Filings/3/0001062993-21-002470
3//SEC Filing

Schroder Adveq cPl Global Management III L.P. 3

Accession 0001062993-21-002470

CIK 0001656536other
View on SEC.govCompany Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:34 PM ET

Size

11.6 KB

Accession

0001062993-21-002470

Insider Transaction Report

Form 3
Period: 2021-02-11
Decibel Therapeutics, Inc.DBTX
Schroder Adveq Technology IX S.C.S.
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)
Schroder Adveq cPl Global Management III L.P.
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)
Schroder Adveq cPl Global 2017 - 2019 C.V.
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)
Schroder Adveq Management Luxembourg Sarl
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (524,328 underlying)
Footnotes (3)
  • [F1]Each share of Series C Preferred Stock is convertible into shares of the Issuer???s common stock, $0.001 per value per share, on a 12.635:1 basis at any time at the holder???s election and will automatically convert immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock has no expiration date.
  • [F2]Held directly by Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg S.a.r.l. is the general partner of Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg S.a.r.l. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F3]Held directly by Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. is the general partner of Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

Documents

1 file

Issuer

Decibel Therapeutics, Inc.

CIK 0001656536

→
Entity typeother
IncorporatedNetherlands Antilles

Related Parties

1
  • filerCIK 0001848942

Filing Metadata

Form type
3
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:34 PM ET
Size
11.6 KB
View on SEC.gov